Clinical Effectiveness of Dolutegravir in the Treatment of HIV/AIDS

Infection and Drug Resistance - New Zealand
doi 10.2147/idr.s68396
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The Everyday Life Uncertainties of HIV/AIDS Diseased Bodies in the Era of HIV/AIDS Treatment in Kenya

Sociology and Anthropology
2018English

Critical Appraisal of Elvitegravir in the Treatment of HIV-1/AIDS

HIV/AIDS - Research and Palliative Care
DermatologyHealth PolicyVirologyInfectious DiseasesEpidemiology
2014English

Barriers to HIV/AIDS Treatment in Nigeria

American Journal of Health Research
2015English

The Effectiveness and Ethical Reporting of HIV and AIDS Coverage in South African Media

JOURNAL OF COMMUNICATION
2018English

The Economic Burden of HIV/AIDS and Myocardial Infarction Treatment in Brazil

The Scientific World Journal
BiochemistryMedicineGeneticsMolecular BiologyEnvironmental Science
2013English

Corrigendum: 7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir

Angewandte Chemie - International Edition
CatalysisChemistry
2018English

Control of Corruption, Democratic Accountability, and Effectiveness of HIV/AIDS Official Development Assistance

Global Health Action
Health PolicyPublic HealthOccupational HealthEnvironmental
2016English

Evaluation of Clinical and Immunological Markers for Predicting Virological Failure in a HIV/AIDS Treatment Cohort in Busia, Kenya

PLoS ONE
Multidisciplinary
2012English

Berichtigung: 7-Step Flow Synthesis of the HIV Integrase Inhibitor Dolutegravir

Angewandte Chemie
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy